• BX Home
  • Pharmaceuticals Companies: News

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

PHARMACEUTICALS COMPANIES

The phrase "Big Pharma" is often used to refer to pharmaceutical companies with revenue in excess of $3 billion, and/or R&D expenditures in excess of $500 million. It is these pharmaceutical companies that are shaping the future of medicine. This topic covers the latest news and views on the companies behind the pharmaceuticals

10 largest are Johnson and Johnson, Pfizer, Bayer, GlaxoSmithKline, Novartis, Sanofi-Aventis, Hoffmann-La Roche, Astra Zeneca, Merck & Co., Abbott Laboratories.


Pharmaceuticals Companies is part of Business Exchange, suggested by Henri TCHEN. This topic contains 2,866 news and 3,071 blog items. Read updated news, blogs, and resources about Pharmaceuticals Companies. Find user-submitted articles and reactions on Pharmaceuticals Companies from like-minded professionals.

News

Recent news on this topic.

Jury Awards $28 Million in Hormone-Therapy Suitmore

defendant in the case. "We hope that the jury's verdict will send a message to these giant pharmaceutical...

Jane Brody Explains Low-Acid Eatingmore

or meat and dairy products. I?m glad to see Ms. Brody for once entertaining ideas not sponsored by Big Pharma or Big...

Vioxx and Heart Attack Linked in 2001more

Extract not available.

Pa. Jury Orders Pfizer To Pay $28 Million In Punitive Damagesmore

defendant in the case. 'We hope that the jury's verdict will send a message to these giant pharmaceutical companies...

Europe drug stocks rally; U.S. indexes mixedmore

into the U.S. market, with the Dow Jones Industrial Average rising 125 points to 10,443. European Big Pharma stocks...

Pharma Companies Navigate Sunshine Act and Doctor Payments, According ...more

care bill, the proposed law aims to create more transparency in industry-doctor relationships. Smaller legislative...

Which Drug Companies Could Be Private-Equity Targets?more

The recent $4 billion private-equity buyout of IMS Health raises an irresistible question: What other health-care...

View from the Top: Chris Viehbacher, Sanofi-Aventismore

manage, and we killed the innovative spirit. So big acquisitions are not on our radar screen. Is the big pharma model...

What's the most affordable city for houses?more

industry, which Indianapolis had been closely associated with, has hurt the city. But increased diversification, which...

Counterfeit Drugs and Internet Smartsmore

is no evidence this helps Turkish patients, and it certainly restricts their choices. Although convenient for patients,...

WRAPUP 1-Healthcare reform faces challenges in U.S. Senatemore

Richard Durbin, the Senate's No. 2 Democrat. 'It has been,' Durbin said on 'Meet the Press' Sunday. Pharmaceutical...

FACTBOX-Winners, losers in U.S. Senate health billmore

and others. Wider insurance coverage could help offset the industry's costs by providing more potential customers.

Shop for Dividends in This Bull Marketmore

that they have confidence in the future.' What are her picks right now? Ms. Saryan likes many big drug companies,...

Innovation Goes Downtownmore

are filled with 1,000 scientists working in seven public research institutes and the labs of such big pharmaceutical...

Drug firms tired song and dance on reformmore

IN MAKING a fool of President Obama, Big Pharma has turned itself into a poison pill of health care reform.

EDITORIAL: Promises of drug industry fall flat: AS PRICES INCREASE, CO...more

Democrat who was one of the key forces behind the House health-care bill, said this transfer provided the drug...

Big Pharma Mergers: Good News Or Bad?more

Whoever says you can't throw money at problems hasn't spent much time following the Big Pharma sector this year.

The Health-Care Buffetmore

While lawmakers like to vilify insurance and pharmaceutical companies for driving up health-care costs to make fat...

Research and Markets: Analyzing the Generic Drugs Sector of the US Pha...more

existing drug in order to gain regulatory approval. It has been estimated that the average cost to brand-name drug...

Moodys on Pharma: Outlook Is Negative, But it Could Be Worsemore

Moodys still thinks the credit ratings of the worlds big drug companies are likely to get worse in the coming months.

Why Pharma Doesn't Twittermore

uses social networks to consult one another on symptoms, diagnoses, and treatments, according to surveys on Web...

Research and Markets: Strategies for Building Early-Stage Pharmaceutic...more

Through External Sources' to their offering. Under tremendous pressure to refuel dwindling development pipelines and...

The Six Entrepreneurs You Meet in China: 2more

those same big companies. Which ones, you ask? Pharmaron won't let me tell. Western electronics, gadget, and...

How We Pay for Big Pharma's Malpracticemore

One reason drug companies need additional revenue is because employee whistleblowers have found the nerve to report the...

ANALYSIS-U.S. losing ground to Europe in new drug approvalsmore

more global submissions,' he said on the sidelines of a conference in London this week. In the past, drug companies...

Top Sources: Pharmaceuticals Companies

  • 247wallst.com
  • Reuters
  • online.wsj.com
  • BusinessWeek
  • International Herald Tribune
  • Mail Online UK
  • New York Times
  • phrma.org
  • adage.com
  • bloomberg.com

Most Active Users in this Topic

see all contributors...

Featured White Papers

Post a Job

Jobs in this Topic

Medical Director, Cystic Fibrosis Vertex Pharmaceuticals | Cambridge, MA
Posted: Nov 20
Director, Business Development - Must have CNS, CRO exp Pharmaceuticals Company | Hamilton, NJ
Posted: Oct 17
District Sales Manager Teva Pharmaceuticals | San Diego, CA
Posted: Nov 6
Clinical Data Study Lead Vertex Pharmaceuticals | Cambridge, MA
Posted: Nov 7
Medical Director - Anti-Infectives Cubist Pharmaceuticals | Lexington, MA
Posted: Nov 23

Report comment contains invalid characters. ()
cancel
Search Cancel